Mankind Pharma Stock Surges: Know Reason Behind Sudden Spike

Mankind Pharma Share Price: The stock price of Mankind Pharma, a leading pharmaceutical company in India has witnessed a sudden rise.
mankind pharma, mankind pharma share price, mankind pharma stock price, mankind pharma shares, mankind pharma stocks

Mankind Pharma Stock Surges: Know Reason Behind Sudden Spike

Mankind Pharma, a leading pharmaceutical company in India, saw its stock price rise by up to 5.27 per cent to Rs 2,215 per share on the BSE during Wednesday's intraday trade. This increase followed the sale of approximately 3.7 million shares, representing a 0.9 per cent equity stake in the company, through block deals worth Rs 771 crore.

Who Were Sellers Of The Share Sale?

Reports suggest that the seller was likely Hema CIPEF, an affiliate of Capital Group, which previously held a 2.22 per cent stake in Mankind Pharma. On Tuesday, news emerged that Hema CIPEF planned to sell a 0.9 per cent stake in the company at Rs 2,061 per share through block deals.

Mankind Pharma Mcap

Mankind Pharma, a large-cap firm, has a total market capitalization of Rs 86,078 crore.

Mankind Pharma Shares PE Ratio

Its shares are currently trading at a price-to-earnings multiple of 46.22 times, with an earnings per share of Rs 45.52, according to BSE data.

Mankind Pharma Share Price

As of 10:40 AM on Wednesday, the stock was trading 2.12 per cent higher at Rs 2,148.55 per share on the BSE. In contrast, the BSE Sensex fell by 1.01 per cent to 79,539 levels.
Mankind Pharma Financial Performance: Net Profit
In the March quarter of FY24, Mankind Pharma reported a notable 65.1 per cent increase in net profit, which rose to Rs 471.2 crore from Rs 285.4 crore in the same period the previous year.

Mankind Pharma March Quarter Results: Revenue

Revenue also grew by 19 per cent, reaching Rs 2,441.1 crore compared to Rs 2,052.7 crore year-on-year.
Mankind Pharma: EBITDA
The company's operating profit (EBITDA) surged by 41.8 per cent to Rs 591.1 crore, up from Rs 416.7 crore in the same quarter last year.
Mankind Pharma: EBITDA Margin
Additionally, the EBITDA margin improved to 24.2 per cent from 20.3 per cent in the previous fiscal year.
About Mankind Pharma
Based in Delhi, Mankind Pharma is well-known for its wide range of healthcare products, including antibiotics, gastrointestinal, cardiovascular, dermal, and erectile dysfunction medications. The company primarily focuses on the domestic market.
End of Article
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news
news